Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $14.63 million.

GUIDANCE:

Apyx Medical Corp. sees FY2022 revenue of $50-63 million, versus the consensus of $59.9 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.